政井 恭兵

Medicine & Life Sciences

1. Adenocarcinoma of Lung 100%
2. Lung Neoplasms 71%
3. Non-Small Cell Lung Carcinoma 70%
4. Lung 69%
5. Neoplasms 56%
6. Adenocarcinoma 50%
7. Desmocollins 46%
8. Neuroendocrine Carcinoma 43%
9. Idiopathic Pulmonary Fibrosis 41%
10. Malignant Mesothelioma 38%
11. Recurrence 34%
12. Neoplasm Metastasis 33%
13. Squamous Cell Carcinoma 32%
14. Keratin-5 30%
15. Angiosarcoma of the breast 29%
16. S 1 (combination) 28%
17. Air 27%
18. Lymph Nodes 27%
19. Tomography 26%
20. Respiratory Paralysis 26%
21. Segmental Mastectomy 25%
22. Pulmonary Surfactants 24%
23. Keratin-19 23%
24. Thymoma 23%
25. Retrospective Studies 23%
26. Mutation 22%
27. Video-Assisted Thoracic Surgery 21%
28. Cryosurgery 21%
29. Safety 20%
30. ErbB Receptors 20%
31. Colloids 20%
32. Combination Drug Therapy 19%
33. Chemokine Receptors 19%
34. Breast Neoplasms 19%
35. Large Cell Carcinoma 19%
36. Survival 19%
37. Local Anesthesia 18%
38. Thoracotomy 18%
39. Hemangiosarcoma 18%
40. Pleura 17%
41. Carcinoma 17%
42. Tumor Cell Line 17%
43. Glass 16%
44. Lymph Node Excision 15%
45. Therapeutics 15%
46. Pneumonia 14%
47. Diabetes Mellitus 13%
48. Swine 13%
49. Thorax 13%
50. Carcinoid Tumor 13%